Phio Pharmaceuticals Corp...

NASDAQ: PHIO · Real-Time Price · USD
2.19
-0.08 (-3.31%)
At close: Jun 23, 2025, 3:59 PM
2.16
-1.14%
After-hours: Jun 23, 2025, 05:35 PM EDT
-3.31%
Bid 2.16
Market Cap 10.48M
Revenue (ttm) n/a
Net Income (ttm) -6.76M
EPS (ttm) -9.02
PE Ratio (ttm) -0.24
Forward PE -2.84
Analyst Buy
Ask 2.36
Volume 112,292
Avg. Volume (20D) 3,327,046
Open 2.22
Previous Close 2.27
Day's Range 2.16 - 2.24
52-Week Range 0.97 - 9.79
Beta 0.85

About PHIO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 weeks ago
+17.14%
Phio Pharmaceuticals shares are trading higher HC ... Unlock content with Pro Subscription
1 month ago
+18.6%
Phio Pharmaceuticals shares are trading higher after the company announced pathology results from the third cohort in its INTASYL PH-762 skin cancer clinical trial.